(IN BRIEF) In the Phase 3 IsKia trial presented at the American Society of Hematology (ASH) Annual Meeting, Sarclisa® (isatuximab)…
BIRMINGHAM, 14-Jul-2016 — /EuropaWire/ — Researchers from the University of Birmingham and hospitals across the West Midlands have revealed how a…